-
Time Magazine piece on treatment of early Alzheimer’s Disease lacks balance. It reads as an ad for pharma company that made it. Side effects glossed over and relative instead of absolute risk reported. Clinical outcomes overstated.
Medical Mythbusting Commentary for October 27, 2023 Source:Why Diagnosing Alzheimer’s Early Is So Important Reference:Lecanemab for Alzheimer’s disease: tempering hype and hope